Structure-Based Dissection of the Active Site Chemistry of Leukotriene A4 Hydrolase: Implications for M1 Aminopeptidases and Inhibitor Design

被引:75
|
作者
Tholander, Fredrik [1 ]
Muroya, Ayumo [2 ]
Roques, Bernard-Pierre [3 ]
Fournie-Zaluski, Marie-Claude [4 ]
Thunnissen, Marjolein M. G. M. [2 ]
Haeggstrom, Jesper Z. [1 ]
机构
[1] Karolinska Inst, Dept Med Biochem & Biophys, Div Chem 2, S-17177 Stockholm, Sweden
[2] Lund Univ, Kemicentrum, Dept Mol Biophys, S-22100 Lund, Sweden
[3] UFR Sci Pharmaceut & Biol, Dept Pharmacochim Mol & Struct, F-75270 Paris 06, France
[4] Paris Biopark, Pharmaleads, Paris, France
来源
CHEMISTRY & BIOLOGY | 2008年 / 15卷 / 09期
基金
瑞典研究理事会;
关键词
D O I
10.1016/j.chembiol.2008.07.018
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
M1 aminopeptidases comprise a large family of biologically important zinc enzymes. We show that peptide turnover by the M1 prototype, leukotriene A4 hydrolase/aminopeptidase, involves a shift in substrate position associated with exchange of zinc coordinating groups, while maintaining the overall coordination geometry. The transition state is stabilized by residues conserved among M1 members and in the final reaction step, Glu-296 of the canonical zinc binding HEXXH motif shuffles a proton from the hydrolytic water to the leaving group. Tripeptide substrates bind along the conserved GXMEN motif, precisely occupying the distance between Glu-271 and Arg-563, whereas the Arg specificity is governed by a narrow S1 pocket capped with Asp-375. Our data provide detailed insights to the active site chemistry of M1 aminopeptidases and will aid in the development of novel enzyme inhibitors.
引用
收藏
页码:920 / 929
页数:10
相关论文
共 19 条
  • [1] Binding of Pro-Gly-Pro at the active site of leukotriene A4 hydrolase/aminopeptidase and development of an epoxide hydrolase selective inhibitor
    Stsiapanava, Alena
    Olsson, Ulrika
    Wan, Min
    Kleinschmidt, Thea
    Rutishauser, Dorothea
    Zubarev, Roman A.
    Samuelsson, Bengt
    Rinaldo-Matthis, Agnes
    Haeggstrom, Jesper Z.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (11) : 4227 - 4232
  • [2] Crystal structure of leukotriene A4 hydrolase in complex with kelatorphan, implications for design of zinc metallopeptidase inhibitors
    Tholander, Fredrik
    Rogues, Bernard-Pierre
    Fournie-Zaluski, Marie-Claude
    Thunnissen, Marjolein M. G. M.
    Haeggstrom, Jesper Z.
    FEBS LETTERS, 2010, 584 (15) : 3446 - 3451
  • [3] Identification of Human Leukotriene A4 Hydrolase Inhibitors Using Structure-Based Pharmacophore Modeling and Molecular Docking
    Audat, Suaad A.
    Al-Shar'i, Nizar A.
    Al-Oudat, Buthina A.
    Bryant-Friedrich, Amanda
    Bedi, Mel F.
    Zayed, Aref L.
    Al-Balas, Qosay A.
    MOLECULES, 2020, 25 (12):
  • [4] Structure-based design of an inhibitor modeled at the substrate active site of aldose reductase
    Rastelli, G
    Vianello, P
    Barlocco, D
    Costantino, L
    DelCorso, A
    Mura, U
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1997, 7 (14) : 1897 - 1902
  • [5] Coupling structure-based design with combinatorial chemistry: application of active site derived pharmacophores with informative library design
    Eksterowicz, JE
    Evensen, E
    Lemmen, C
    Brady, GP
    Lanctot, JK
    Bradley, EK
    Saiah, E
    Robinson, LA
    Grootenhuis, PDJ
    Blaney, JM
    JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2002, 20 (06): : 469 - 477
  • [6] Determination of the active site protonation state of β-secretase from molecular dynamics simulation and docking experiment:: Implications for structure-based inhibitor design
    Park, H
    Lee, S
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2003, 125 (52) : 16416 - 16422
  • [7] Modelling studies of the active site of human sorbitol dehydrogenase: An approach to structure-based inhibitor design of the enzyme
    Darmanin, C
    El-Kabbani, O
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (24) : 3133 - 3136
  • [8] Discovery and clinical progression of highly selective M1 agonists utilizing structure-based drug design
    Brown, Giles
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
  • [9] Combining Dyad Protonation and Active Site Plasticity in BACE-1 Structure-Based Drug Design
    Kacker, Puneet
    Masetti, Matteo
    Mangold, Martina
    Bottegoni, Giovanni
    Cavalli, Andrea
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2012, 52 (05) : 1079 - 1085
  • [10] Structure-activity relationship studies on 1-[2-(4-phenylphenoxy)ethyl]pyrrolidine (SC-22716), a potent inhibitor of leukotriene A4 (LTA4) hydrolase
    Penning, TD
    Chandrakumar, NS
    Chen, BB
    Chen, HY
    Desai, BN
    Djuric, SW
    Docter, SH
    Gasiecki, AF
    Haack, RA
    Miyashiro, JM
    Russell, MA
    Yu, SS
    Corley, DG
    Durley, RC
    Kilpatrick, BF
    Parnas, BL
    Askonas, LJ
    Gierse, JK
    Harding, EI
    Highkin, MK
    Kachur, JF
    Kim, SH
    Krivi, GG
    Villani-Price, D
    Pyla, EY
    Smith, WG
    Ghoreishi-Haack, NS
    JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (04) : 721 - 735